Now Reading
Join Biogen and other leading institutions for an important discussion on climate, health, and equity
Join Biogen and other leading institutions for an important discussion on climate, health, and equity
Published 09-10-20
Submitted by Biogen
Health or the economy? Climate or jobs? Equity or affordability?
These questions define our time and will be debated during Climate Week and beyond.
But what if we don’t have to choose? Biogen believes it is time to usher in a new era of “both / and” climate commitments.
Register now for an insider’s look at Biogen’s major new corporate commitment to climate, health and equity.
September 14th, 10am EST via Zoom
Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Biogen is advancing a pipeline of potential novel therapies across neurology, neuropsychiatry, specialized immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.
More from Biogen
